Dammam
This manufacturing site is located in the second industrial city of Dammam in the Kingdom of Saudi Arabia. The site area is about 14,000 square meters and the built-up area is about 17,000 square meters. The plant’s high standards of quality and automation at various stages of the manufacturing process have led to its classification as one of the most advanced manufacturing sites in the region. A specialized section of the Dammam site has been allocated for injectables. This has enabled Tabuk Pharmaceuticals to further penetrate the Saudi and regional markets with new medications including contrast media used in medical imaging, in addition to general anesthetics. Dammam plant is the first manufacturing facility in the Kingdom of Saudi Arabia to manufacture lyophilized vials. The plant also manufactures other pharmaceutical preparations such as creams, ointments, nasal sprays, and other liquid dosage forms. This site is managed by a team of more than 200 employees.
The annual production capacity of this plant is around 50 million (Base Unit Measurement) including liquid vials, lyophilized vials, and ampoules.